Nkarta, Inc.

The recent FDA clearance of our Investigational New Drug (IND) application in three additional #autoimmune diseases takes us one step closer to realizing our mission of bringing transformative #NKcell therapy to patients in need. We’re committed to improving the quality of life for people living with scleroderma, vasculitis and myositis.

We’re dedicated to building awareness of ANCA vasculitis and #autoimmune disease, while advancing the promise of #NKcell therapy to improve accessibility for people living with this disease.

#InternSpotlight: We are grateful for our summer interns! This incredible group took on key projects that support our mission to deliver safe and accessible cell therapies to people living with autoimmune disease and cancer. They made a significant impact, and integrated seamlessly into our team, bringing hard work and enthusiasm.    Thank you, Mya Jefferies, Aaron Susantin, Raymond Ruiz, Lilian Barbosa, Chris S., Nidia Rodriguez, and Nicole C. – best of luck in everything you do!

Through our ongoing partnership with Life Science Cares Bay Area, we volunteered with Northern Marin Community Services and Upward Scholars to prepare 200+ backpacks filled with school essentials for students in need. These backpacks will benefit students from kindergarten through college. We look forward to more opportunities to support our local community! 

The next frontier of #NKcell therapy has the potential to uncover new treatment options for patients in need. One area of autoimmune disease we are focused on is myositis. Watch and learn more about the signs and symptoms people living with this disease experience. 

We’re committed to redefining the autoimmune disease treatment landscape by harnessing the body’s natural killer cells – the immune system’s first responders – to deliver a cell therapy that is safer, more tolerable and more accessible to people living with serious autoimmune diseases, including systemic sclerosis. Watch and learn more:  

We’re working to expand the capabilities of #NKcell therapy and address unmet patient needs in autoimmune disease indications such as ANCA Vasculitis. Watch and learn more about how symptoms can manifest.

Autoimmune disease represents an area of immense patient need. Hear from David Shook, M.D. on how our passion for patient-centric care translates into our mission to re-define the autoimmune disease treatment landscapes.  

Hear from our CEO, Paul Hastings, on our vision for the future of NK cell therapy in autoimmune disease, including #lupus. 

Thank you, Life Science Cares Bay Area for your partnership and for connecting us with non-profits such as BioLink Depot to help the local community.